PAQ Therapeutics raises $77M in Series B extension funding to support the Phase 1 development of PT0253 and clinical advancement of PT0511.
Amount Raised
$77 Million
Round Type
Series B
BurlingtonBiotechnologyHealth CareTherapeuticsDescription
PAQ Therapeutics, a Burlington, MA-based clinical-stage oncology company, raised a Series B extension funding. This brought the total Series B funding to $77M. The company plans to use the funds for its ongoing Phase 1 development of PT0253 and the clinical advancement of PT0511. The funding follows previously announced financing with participation from both existing and new investors.
Quick answer
PAQ Therapeutics raised $77 Million in a Series B round, dated January 26, 2026. PAQ Therapeutics is based in Burlington, Massachusetts, United States.
- How much did PAQ Therapeutics raise?
- PAQ Therapeutics raised $77 Million in a Series B round on January 26, 2026.
- What does PAQ Therapeutics do?
- PAQ Therapeutics is a biotechnology company pioneering a new approach to restoring heath and curing disease through autophagy, the body’s most versatile mechanism for natural cellular degradation.
- Where is PAQ Therapeutics based and how big is it?
- PAQ Therapeutics is based in Burlington, Massachusetts, United States. Fundz records about 8 employees.
- Who are the decision-makers at PAQ Therapeutics?
- Fundz holds 1 contact at PAQ Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as PAQ Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Combat Medical raised $3.5M (Series A) on March 12, 2026.
- GenSight Biologics raised $2M (Post-IPO Equity) on March 10, 2026.
- Prolium Bioscience raised $50M (Series A) on March 5, 2026.
- NexCure raised $19M (Series A) on March 5, 2026.
- Os Therapies raised $2M on March 4, 2026.
- Antiverse raised $9.3M (Series A) on March 3, 2026.
Who to call at PAQ Therapeutics, and when
A new round usually means PAQ Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day PAQ Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at PAQ Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at PAQ Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment PAQ Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansPAQ Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.